Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

126.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 21,785
  • Market Cap: £132.01m
  • RiskGrade: 90
  • Beta: 0.00

Latest ShareCast News

Cello Health revenues and headline profits grow in Q1

By Iain Gilbert

Date: Wednesday 08 May 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.

Cello Health Regulatory News

Director/PDMR Shareholding 20-Jun-2019 16:29 RNS
Total Voting Rights 10-Jun-2019 09:41 RNS
Block listing Interim Review 24-May-2019 12:45 RNS
Issue of Equity 20-May-2019 16:29 RNS
Holding(s) in Company 15-May-2019 07:00 RNS

Cello Health News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 126.00p
Change Today 1.00p
% Change 0.80 %
52 Week High 139.50
52 Week Low 96.00
Volume 21,785
Shares Issued 104.77m
Market Cap £132.01m
Beta 0.00
RiskGrade 90

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
37.21% above the market average37.21% above the market average37.21% above the market average37.21% above the market average37.21% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income
22.39% below the market average22.39% below the market average22.39% below the market average22.39% below the market average22.39% below the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
Growth
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 24-Jun-2019

Time Volume / Share Price
10:06 7,472 @ 125.10p
09:12 9,345 @ 126.50p
08:35 773 @ 125.00p
08:23 2,097 @ 126.00p
08:15 2,098 @ 126.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page